Alpha 2.0
Login Register
» Articles » PMID: 19058210

Utility of FDG-PET/CT in the Follow-up of Neuroblastoma Which Became MIBG-negative

Overview
Journal Pediatr Blood Cancer
Specialties Hematology
Oncology
Pediatrics
Date 2008 Dec 6
PMID 19058210
Citations 7
Authors
Heather Mc Dowell
Paul Losty
Nik Barnes
George Kokai
Affiliations
Soon will be listed here.
Citing Articles

Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments.

Samim A, Tytgat G, Bleeker G, Wenker S, Chatalic K, Poot A J Pers Med. 2021; 11(4).

PMID: 33916640 PMC: 8066332. DOI: 10.3390/jpm11040270.

Guidelines on nuclear medicine imaging in neuroblastoma.

Bar-Sever Z, Biassoni L, Shulkin B, Kong G, Hofman M, Lopci E Eur J Nucl Med Mol Imaging. 2018; 45(11):2009-2024.

PMID: 29938300 DOI: 10.1007/s00259-018-4070-8.

Usefulness of 18F-Fluorodeoxyglucose Positron Emission Tomography for Follow-Up of 13-cis-Retinoic Acid Treatment for Residual Neuroblastoma After Myeloablative Chemotherapy.

Sato Y, Kurosawa H, Sakamoto S, Kuwashima S, Hashimoto T, Okamoto K Medicine (Baltimore). 2015; 94(31):e1290.

PMID: 26252303 PMC: 4616575. DOI: 10.1097/MD.0000000000001290.

Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography/computed tomography: a review of literature.

Kandathil A, Wong K, Wale D, Zatelli M, Maffione A, Gross M Endocrine. 2014; 49(1):6-26.

PMID: 25273320 DOI: 10.1007/s12020-014-0440-6.

Nuclear medicine and multimodality imaging of pediatric neuroblastoma.

Mueller W, Coppenrath E, Pfluger T Pediatr Radiol. 2012; 43(4):418-27.

PMID: 23151727 DOI: 10.1007/s00247-012-2512-1.